The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include treatment of adults with Crohn’s disease and ulcerative colitis.
Tim Ducharme, vice president of Immunization Growth and Strategy at CVS Health, discusses the company’s vaccination business and its offerings for the respiratory virus season.
Kroger also extended the expiration date for the related solicitations of consents to adopt certain proposed amendments to the indentures governing the ACI Notes.